Effects of a Multi-Component Behavioral Intervention (MCI) for Insomnia on Depressive and Insomnia Symptoms in Individuals with High and Low Depression

Journal of Evidence-informed Social Work
Kirsten JohnsonDana R Epstein

Abstract

Insomnia and depression are prevalent and co-occurring conditions that are associated with significant impairment of life. Previous research indicates that cognitive-behavioral interventions for insomnia (CBT-I) can improve both insomnia and depressive symptoms. The aim of the authors in this study was to determine whether a multi-component behavioral intervention (MCI) improved both insomnia and depressive symptoms in persons presenting with insomnia and high levels of depression. The sample consisted of 321 individuals with insomnia who participated in a trial of insomnia treatments; 106 participants had high levels of depression (score ≥ 16 on CES-D) at baseline. Participants either received the MCI or a control treatment (sleep education and hygiene booklet). At post-test, participants with high and low levels of depressive symptoms showed significant improvement in insomnia symptoms. Those with high depression also had significant reductions in depressive symptoms. It can be concluded that for individuals with depression and insomnia, CBT-I is a viable intervention for managing depressive symptoms, which complements other approaches for treating depression.

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
May 1, 1993·The American Journal of Psychiatry·W CoryellG L Klerman
Jul 24, 1998·Comprehensive Psychiatry·M M OhayonP Lemoine
Jul 17, 2001·Biological Psychology·D RiemannU Voderholzer
Jan 5, 2002·The American Journal of Psychiatry·Michael T SmithDaniel J Buysse
Apr 6, 2004·Sleep Medicine Reviews·Ripu D Jindal, Michael E Thase
Mar 15, 2005·General Hospital Psychiatry·Michael E Thase
Dec 13, 2005·Sleep·Daniel J TaylorAndrew J Bush
Feb 2, 2006·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Michael R IrwinPerry M Nicassio
Apr 4, 2006·Behavioral Sleep Medicine·Michael L PerlisXin Tu
Sep 19, 2006·Journal of Psychiatric Research·Eric O JohnsonNaomi Breslau
Sep 23, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Scott B PattenNady El-Guebaly
Feb 13, 2007·Behavior Therapy·Daniel J TaylorJeff R Temple
Aug 25, 2007·Annual Review of Clinical Psychology·Richard R Bootzin, Dana R Epstein
May 13, 2009·Research in Nursing & Health·Souraya SidaniJoyal Miranda
Jul 17, 2009·Behaviour Research and Therapy·Souraya SidaniPatricia Moritz
Oct 14, 2009·Indian Journal of Psychiatry·Ravi GuptaManjeet Singh Bhatia
Nov 27, 2009·Sleep Medicine Reviews·Luc Staner
May 1, 2006·Expert Review of Clinical Immunology·Sally E ThomsonStephen M Twigg
Dec 24, 2010·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland
Feb 9, 2011·Journal of Affective Disorders·Chiara BaglioniDieter Riemann
May 11, 2011·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland
Jun 15, 2011·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland
Aug 3, 2011·Disease-a-month : DM·Thomas Freedom
Oct 1, 2011·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Charles M MorinJoseé Savard
Dec 16, 2011·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Rachel ManberJason C Ong

❮ Previous
Next ❯

Citations

Nov 25, 2018·Archives of Gynecology and Obstetrics·Alhambra FrareyCourtney A Schreiber

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.